Manufacturer
HRA Pharma Rare Diseases
- Products listed
- 2
- Molecules
- 2
- Therapy areas
- 2
HRA Pharma Rare Diseases is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 2 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply HRA Pharma Rare Diseases products through licensed channels, with the documents your regulator needs.
Oncology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Lysodren 500 mg tabletOral | Mitotane | US FDA | Available on request |
Contrast media and diagnostics
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Metopirone 250 mg capsuleOral | Metyrapone | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from HRA Pharma Rare Diseases
Send a request for any of these products. We confirm the licensed source, documents and lead time.